Intellia Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Intellia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Intellia Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intellia Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.4M | 313k | 17.27 |
| 2025-06-30 | $2.9M | 311k | 9.38 |
| 2025-03-31 | $2.0M | 282k | 7.11 |
| 2024-12-31 | $3.3M | 285k | 11.66 |
| 2024-09-30 | $5.9M | 288k | 20.55 |
| 2024-06-30 | $8.2M | 364k | 22.38 |
| 2024-03-31 | $10M | 362k | 27.51 |
| 2023-12-31 | $12M | 394k | 30.49 |
| 2023-09-30 | $13M | 400k | 31.62 |
| 2023-06-30 | $16M | 399k | 40.78 |
| 2023-03-31 | $14M | 368k | 37.27 |
| 2022-12-31 | $7.2M | 379k | 19.00 |
| 2022-09-30 | $0 | 342k | 0.00 |
| 2022-06-30 | $15M | 300k | 51.42 |
| 2022-03-31 | $21M | 295k | 72.80 |
| 2021-12-31 | $0 | 296k | 0.00 |
| 2021-09-30 | $40M | 299k | 133.94 |
| 2021-06-30 | $43M | 263k | 161.91 |
| 2021-03-31 | $16M | 203k | 80.26 |
| 2020-12-31 | $11M | 205k | 54.41 |
| 2020-09-30 | $3.7M | 188k | 19.88 |
| 2020-06-30 | $3.9M | 187k | 21.03 |
| 2020-03-31 | $2.1M | 173k | 12.23 |
| 2019-12-31 | $3.3M | 224k | 14.67 |
| 2019-09-30 | $2.9M | 215k | 13.36 |
| 2019-06-30 | $2.4M | 148k | 16.37 |
| 2019-03-31 | $2.1M | 126k | 17.08 |
| 2018-12-31 | $1.7M | 123k | 13.64 |
| 2018-09-30 | $3.8M | 131k | 28.63 |
| 2018-06-30 | $3.4M | 124k | 27.36 |
| 2018-03-31 | $1.7M | 80k | 21.10 |
| 2017-12-31 | $1.4M | 73k | 19.22 |
| 2017-06-30 | $876k | 55k | 15.98 |
| 2017-03-31 | $446k | 32k | 14.08 |
| 2016-12-31 | $394k | 30k | 13.15 |
| 2016-09-30 | $356k | 21k | 17.27 |
| 2016-06-30 | $467k | 22k | 21.58 |